ArticleFrontiers in cardiovascular medicine2022

In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study.

Arturo Cesaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.